Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $850.8100 (-0.52%) ($850.8100 - $859.1100) on Mon. Dec. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.16% (three month average) | RSI | 70 | Latest Price | $850.8100(-0.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(74%) IVE(69%) XLV(66%) XLF(65%) XLU(64%) | Factors Impacting REGN price | REGN will decline at least -0.58% in a week (0% probabilities). VIXM(-61%) UNG(-31%) BNDX(-14%) TBT(-13%) UUP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.58% (StdDev 1.16%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $864.23(-1.55%) | 10 Day Moving Average | $852.32(-0.18%) | 20 Day Moving Average | $830.59(2.43%) | To recent high | -2.9% | To recent low | 9.8% | Market Cap | $90.21b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |